US Patent 7511024 Factor VII or VIIA-like molecules
Patent 7511024 was granted and assigned to Bayer Healthcare on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Anders Hjelholt Pedersen0
Claus Bornaes0
Kim Vilbour Andersen0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+302 characters)
Article
Patent abstract
Conjugates of Factor VII (FVII) and Factor VIIa (FVIIA) are provided, as are methods for preparing them. Methods for producing novel polypeptides contributing to the production of such conjugates are provided. Methods of treatment by administering a FVII or FVIIa conjugate are provided.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07511024 Factor VII or VIIA-like molecules US Patent 7511024 Factor VII or VIIA-like molecules
Infobox
Patent Number
07511024
Patent Number
7511024
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07511024 Factor VII or VIIA-like molecules
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07511024
Date of patent
March 31, 2009
Patent application number
11279541
Date Filed
April 12, 2006
Patent primary examiner
Find more entities like US Patent 7511024 Factor VII or VIIA-like molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
